Skip to content

Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation

Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06758427
Acronym
HELICOPTER
Enrollment
2300
Registered
2025-01-03
Start date
2025-02-01
Completion date
2027-10-31
Last updated
2025-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Infection, Non-healing Wound, Nosocomial Infection, Pneumonia, Postoperative Complications, Pseudarthrosis, Surgical Site Infection, Wound Infection

Keywords

long bone fracture, trauma

Brief summary

At least ten percent of trauma patients suffer from any sort of complication. The study aims to identify a risk factor profile to early identify trauma patients at risk.

Detailed description

Trauma patients suffer from a high risk of complications that ranges from soft tissue complications, surgical site infection till bone non-union. Comorbidities are often know to be associated with complications. Also certain blood markers could be identified to be an indicator. However, certain risk factors have only been investigated in small trauma cohorts so far. This study is a prospective multi center cohort trail that aims to collect all clinical data, comorbidities, medication, blood markers in trauma patients after long bone fractures. In a 6 months and one year follow up patients with complications will be identified. Methods of machine learning will help to identify a risk factor profile for certain groups of patients with complications. The aim of the study is to early identify patients at risk for a complication after trauma according to their blood marker, clinical, comorbidity and medication profile.

Interventions

None listed

Sponsors

BG Klinik Murnau
CollaboratorUNKNOWN
BG Trauma Center Ludwigshafen
CollaboratorOTHER
BG Klinikum Duisburg
CollaboratorUNKNOWN
BG Klink Hamburg
CollaboratorUNKNOWN
Unfallkrankenhaus Berlin
CollaboratorOTHER
BG Ambulanz Bremen
CollaboratorUNKNOWN
Bundeswehrkrankenhaus Ulm
CollaboratorUNKNOWN
Paracelsus Universität Salzburg
CollaboratorUNKNOWN
Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years

Inclusion criteria

* acute long bone fracture (humerus, ulna, radius, femur, tibia) with surgical treatment

Exclusion criteria

* associated severe injury (ISS \> 16) * associated traumatic brain injury * associated traumatic spine injury * dementia

Design outcomes

Primary

MeasureTime frameDescription
any complication after long bone fracture6 months, one yearnumber of patients that suffer from a complication after surgical treatment of a primary long bone fracture
Clavien Dindo Classification6 months, one yearClavien Dindo Classification classifies surgical complications. All patients will be classified according to Clavien Dindo after 6 months and one year.

Secondary

MeasureTime frameDescription
Charlson Comorbidity Index (CCI)InitiallyCharlson Comorbidity Index classifies comorbidities of patients. All particiapants will be screened for their comorbidities and classified according to CCI.
number of medicationsinitallyIntake of medication will be assessed and number of medication will be identified.
EuroQual 5 Dimensions Questionnaire (EQ5D5L)initially, 6 months, one year.EQ5D5L will be assessed from each participant to identify their quality of life.
patient reported outcome measure associated with the lone bone fractureinitially, 6 months, one year.patient reported outcome measure will be assessed by each patient that is associated with the lone bone fracture

Countries

Germany

Contacts

Primary ContactMarie K Reumann, MD
mreumann@bgu-tuebingen.de+497071606
Backup ContactMika Rollmann, MD
mrollmann@bgu-tuebingen.de+497071606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026